Cargando…
Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds
Ulcerative colitis (UC) is a chronic lifelong inflammatory disorder of the colon, which, while untreated, has a relapsing and remitting course with increasing risk of progression toward colorectal cancer. Current medical treatment strategies of UC mostly focus on inhibition of the signs and symptoms...
Autores principales: | Chumanevich, Anastasiya A., Chaparala, Anusha, Witalison, Erin E., Tashkandi, Hossam, Hofseth, Anne B., Lane, Corey, Pena, Edsel, Liu, Piaomu, Pittman, Doug L., Nagarkatti, Prakash, Nagarkatti, Mitzi, Hofseth, Lorne J., Chumanevich, Alexander A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352114/ https://www.ncbi.nlm.nih.gov/pubmed/27974688 http://dx.doi.org/10.18632/oncotarget.13894 |
Ejemplares similares
-
Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
por: Chumanevich, Alexander A., et al.
Publicado: (2016) -
Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2
por: Chaparala, Anusha, et al.
Publicado: (2020) -
Pharmacokinetics of Panaxynol in Mice
por: Tashkandi, Hossam, et al.
Publicado: (2020) -
Panaxynol, a bioactive component of American ginseng, targets macrophages and suppresses colitis in mice
por: Chaparala, Anusha, et al.
Publicado: (2020) -
A Limited Role of p53 on the Ability of a Hexane Fraction of American Ginseng to Suppress Mouse Colitis
por: Poudyal, Deepak, et al.
Publicado: (2012)